« Zurück
Startseite /
Recombinant S100 Calcium Binding Protein A8 (S100A8)

Recombinant S100 Calcium Binding Protein A8 (S100A8)

ArtNr	RPB792Mu01-10ug
Hersteller	Cloud-Clone
Menge	10 ug
Quantity options	100 ug 10 ug 1 mg 200 ug 500 ug 50 ug
Kategorie	Neuroscience Neural Lineage Markers Aging & Neurological Disorders Peptides & Proteins Recombinant Proteins Progenitor Markers
Typ	Proteins
Applikationen	WB, SDS-PAGE, other
Specific against	Mouse (Murine, Mus musculus)
Host	E.coli
Konjugat/Tag	HIS
Purity	> 95%
Sequence	Met1ca.Glu89
Citations	Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	MRP8; MIF; 60B8AG; CAGA; CFAG; CGLA; CP-10; L1Ag; NIF; P8; Calgranulin A; Cystic fibrosis antigen; Leukocyte L1 complex light chain; Migration inhibitory factor-related protein 8
Similar products	MIF, MRP8, 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag, NIF, P8, Cystic fibrosis antigen, Leukocyte L1 complex light chain, Migration inhibitory factor-related protein 8, Calgranulin A
Lieferbar
Sequence	Met1ca.Glu89 (Accession # P27005)
Predicted Molecular Mass(KD)	11.5kDa
Purity	> 95%
Uniprot Link	P27005
Item Name	S100 Calcium Binding Protein A8
Alternative Names	MRP8, MIF, 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag, NIF, P8, Calgranulin A, Cystic fibrosis antigen, Leukocyte L1 complex light chain, Migration inhibitory factor-related protein 8
Buffer	PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Traits	Freeze-dried powder
Tag	N-terminal His Tag
Research Area	Tumor immunity; Infection immunity;
Expression System	Prokaryotic expression
Appilcaiton info	Positive Control, Immunogen, SDS-PAGE, WB.
Citation	Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds. Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.